Alex Wiltschko

And the future is here.

And it is unevenly distributed.

So if you wanted to go out and smell a disease in one way, shape, or form, and you had a laboratory like we do, you could do it.

The issue is you couldn't give it to everybody.

And today, you wouldn't necessarily know what about that smell is making me believe or making my system, my algorithm believe that this disease is present or is not present.

So we're missing some things.

The first thing that we're missing that's most important is a lot of data.

So, again, I think it's good to go back to an analogy and think about a time when doctors didn't know that looking at the molecules inside of blood was valuable because that was true 100 years ago, maybe even to the 40s.

I've got a bunch of blood, whatever, right?

Like, I don't know if there's anything interesting in it.

Blood is blood, yeah.

Exactly.

It's like, oh, you've got too much blood.

Get rid of it.

So there was a study that was run, a very profound study called the Framingham Heart Study, and it's named after the town of Framingham, Massachusetts.

And what they did-

is they looked at heart disease of basically everybody in the town.

They just tracked and measured the things that they knew at the time were indicative of heart disease.

And then they did a smart thing, which is they just collected as much data as they could, even if they didn't know what to do with it at the time.

One of those things was they took blood samples and they froze them.